Actavis to refocus pain medication sales in QRxPharma licensing deal

Generic pharmaceutical manufacturer Actavis Group’s U.S. subsidiary has agreed to partner with clinical stage specialty pharmaceutical company QRxPharma in a licensing deal to commercialize acute pain medication MoxDuo IR in the United States, in a move that will reshape the Morristown, New Jersey company’s analgesic sales force for branded products. Under the terms of the […]